# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001640334-19-000191
Filing Date
2019-02-08
Accepted
2019-02-08 16:33:09
Documents
64
Period of Report
2019-02-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | inmune_8k.htm | 8-K | 13744
2 | EX-99.1 | inmune_ex991.htm | EX-99.1 | 34886
3 |  | inmune_ex991img1.jpg | GRAPHIC | 240922
4 |  | inmune_ex991img10.jpg | GRAPHIC | 198794
5 |  | inmune_ex991img11.jpg | GRAPHIC | 191302
6 |  | inmune_ex991img12.jpg | GRAPHIC | 174448
7 |  | inmune_ex991img13.jpg | GRAPHIC | 125757
8 |  | inmune_ex991img14.jpg | GRAPHIC | 113342
9 |  | inmune_ex991img15.jpg | GRAPHIC | 152404
10 |  | inmune_ex991img16.jpg | GRAPHIC | 109274
11 |  | inmune_ex991img17.jpg | GRAPHIC | 190426
12 |  | inmune_ex991img18.jpg | GRAPHIC | 98585
13 |  | inmune_ex991img19.jpg | GRAPHIC | 161836
14 |  | inmune_ex991img2.jpg | GRAPHIC | 349296
15 |  | inmune_ex991img20.jpg | GRAPHIC | 188386
16 |  | inmune_ex991img21.jpg | GRAPHIC | 134960
17 |  | inmune_ex991img22.jpg | GRAPHIC | 208695
18 |  | inmune_ex991img23.jpg | GRAPHIC | 199155
19 |  | inmune_ex991img24.jpg | GRAPHIC | 193152
20 |  | inmune_ex991img25.jpg | GRAPHIC | 169276
21 |  | inmune_ex991img26.jpg | GRAPHIC | 173385
22 |  | inmune_ex991img27.jpg | GRAPHIC | 166302
23 |  | inmune_ex991img28.jpg | GRAPHIC | 196233
24 |  | inmune_ex991img29.jpg | GRAPHIC | 235914
25 |  | inmune_ex991img3.jpg | GRAPHIC | 127562
26 |  | inmune_ex991img30.jpg | GRAPHIC | 142726
27 |  | inmune_ex991img31.jpg | GRAPHIC | 166180
28 |  | inmune_ex991img32.jpg | GRAPHIC | 183128
29 |  | inmune_ex991img33.jpg | GRAPHIC | 157138
30 |  | inmune_ex991img34.jpg | GRAPHIC | 144092
31 |  | inmune_ex991img35.jpg | GRAPHIC | 189834
32 |  | inmune_ex991img36.jpg | GRAPHIC | 120180
33 |  | inmune_ex991img37.jpg | GRAPHIC | 134632
34 |  | inmune_ex991img38.jpg | GRAPHIC | 176988
35 |  | inmune_ex991img39.jpg | GRAPHIC | 142720
36 |  | inmune_ex991img4.jpg | GRAPHIC | 150043
37 |  | inmune_ex991img40.jpg | GRAPHIC | 155964
38 |  | inmune_ex991img41.jpg | GRAPHIC | 195689
39 |  | inmune_ex991img42.jpg | GRAPHIC | 179464
40 |  | inmune_ex991img43.jpg | GRAPHIC | 113686
41 |  | inmune_ex991img44.jpg | GRAPHIC | 126020
42 |  | inmune_ex991img45.jpg | GRAPHIC | 159089
43 |  | inmune_ex991img46.jpg | GRAPHIC | 144000
44 |  | inmune_ex991img47.jpg | GRAPHIC | 186637
45 |  | inmune_ex991img48.jpg | GRAPHIC | 166097
46 |  | inmune_ex991img49.jpg | GRAPHIC | 167297
47 |  | inmune_ex991img5.jpg | GRAPHIC | 127022
48 |  | inmune_ex991img50.jpg | GRAPHIC | 149903
49 |  | inmune_ex991img51.jpg | GRAPHIC | 171818
50 |  | inmune_ex991img52.jpg | GRAPHIC | 201353
51 |  | inmune_ex991img53.jpg | GRAPHIC | 127405
52 |  | inmune_ex991img54.jpg | GRAPHIC | 193998
53 |  | inmune_ex991img55.jpg | GRAPHIC | 127563
54 |  | inmune_ex991img56.jpg | GRAPHIC | 153850
55 |  | inmune_ex991img57.jpg | GRAPHIC | 138564
56 |  | inmune_ex991img58.jpg | GRAPHIC | 176206
57 |  | inmune_ex991img59.jpg | GRAPHIC | 284263
58 |  | inmune_ex991img6.jpg | GRAPHIC | 186008
59 |  | inmune_ex991img60.jpg | GRAPHIC | 194105
60 |  | inmune_ex991img61.jpg | GRAPHIC | 146430
61 |  | inmune_ex991img62.jpg | GRAPHIC | 165013
62 |  | inmune_ex991img7.jpg | GRAPHIC | 110246
63 |  | inmune_ex991img8.jpg | GRAPHIC | 134401
64 |  | inmune_ex991img9.jpg | GRAPHIC | 146177
| Complete submission text file | 0001640334-19-000191.txt |  | 14291750

Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 19580405
SIC: 2836 Biological Products, (No Diagnostic Substances)